Sıirt University is a university located in Siirt, Turkey. It was established in 2007.

During the past decade, Siirt Üniversity Medical Faculty conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Siirt Üniversity Medical Faculty" are "Breast Feeding" (1 trials), "Ectopic Pregnancy" (1 trials), "Gestational Diabetes" (1 trials), "Hyperemesis Gravidarum" (1 trials) and "Maternal-Fetal Relations" (1 trials). Many other conditions were trialed in "Siirt Üniversity Medical Faculty" in a lesser frequency.

Most popular intervention types in "Siirt Üniversity Medical Faculty" are "Diagnostic Test" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blood sample" (2 trials), "Ultrasonographic examination" (1 trials), "oral glucose tolerance test" (1 trials) and "thyroid function tests" (1 trials). Other intervention names were less common.

The vast majority of trials in "Siirt Üniversity Medical Faculty" are 5 trials for "Female" genders.

Currently, there are NaN active trials in "Siirt Üniversity Medical Faculty". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Siirt Üniversity Medical Faculty, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Siirt Üniversity Medical Faculty, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".